APRE
Price
$0.64
Change
-$0.03 (-4.48%)
Updated
Feb 5, 02:23 PM (EDT)
Capitalization
4.63M
Intraday BUY SELL Signals
CALC
Price
$0.59
Change
-$0.07 (-10.61%)
Updated
Feb 5, 02:25 PM (EDT)
Capitalization
9.41M
Intraday BUY SELL Signals
Interact to see
Advertisement

APRE vs CALC

Header iconAPRE vs CALC Comparison
Open Charts APRE vs CALCBanner chart's image
Aprea Therapeutics
Price$0.64
Change-$0.03 (-4.48%)
Volume$279
Capitalization4.63M
CalciMedica
Price$0.59
Change-$0.07 (-10.61%)
Volume$200
Capitalization9.41M
APRE vs CALC Comparison Chart in %
APRE
Daily Signal:
Gain/Loss:
CALC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APRE vs. CALC commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Hold and CALC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (APRE: $0.67 vs. CALC: $0.66)
Brand notoriety: APRE and CALC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 16% vs. CALC: 62%
Market capitalization -- APRE: $4.63M vs. CALC: $9.41M
APRE [@Biotechnology] is valued at $4.63M. CALC’s [@Biotechnology] market capitalization is $9.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whileCALC’s FA Score has 1 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • CALC’s FA Score: 1 green, 4 red.
According to our system of comparison, both APRE and CALC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 4 TA indicator(s) are bullish while CALC’s TA Score has 3 bullish TA indicator(s).

  • APRE’s TA Score: 4 bullish, 4 bearish.
  • CALC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, APRE is a better buy in the short-term than CALC.

Price Growth

APRE (@Biotechnology) experienced а -12.32% price change this week, while CALC (@Biotechnology) price change was -47.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CALC($9.41M) has a higher market cap than APRE($4.63M). APRE YTD gains are higher at: -21.454 vs. CALC (-89.985). APRE has higher annual earnings (EBITDA): -13.8M vs. CALC (-32.41M). CALC (14.1M) and APRE (13.7M) have equal amount of cash in the bank . APRE has less debt than CALC: APRE (0) vs CALC (8.9M). APRE (0) and CALC (0) have equivalent revenues.
APRECALCAPRE / CALC
Capitalization4.63M9.41M49%
EBITDA-13.8M-32.41M43%
Gain YTD-21.454-89.98524%
P/E RatioN/A0.30-
Revenue00-
Total Cash13.7M14.1M97%
Total Debt08.9M-
FUNDAMENTALS RATINGS
APRE: Fundamental Ratings
APRE
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APRECALC
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 28 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
APRE
Daily Signal:
Gain/Loss:
CALC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACIC11.180.11
+0.99%
American Coastal Insurance Corp
WF65.310.39
+0.60%
Woori Financial Group
KNTK41.280.03
+0.07%
Kinetik Holdings
HSDT2.22-0.11
-4.72%
Solana Company
ULY1.97-0.44
-18.26%
Urgently Inc.

APRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APRE has been closely correlated with MREO. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if APRE jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-0.49%
MREO - APRE
69%
Closely correlated
-2.73%
BCAB - APRE
66%
Loosely correlated
+11.06%
LENZ - APRE
66%
Loosely correlated
-5.86%
RZLT - APRE
65%
Loosely correlated
-7.62%
CALC - APRE
65%
Loosely correlated
+8.37%
More

CALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CALC has been closely correlated with VTGN. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CALC jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
+8.37%
VTGN - CALC
88%
Closely correlated
-3.20%
MREO - CALC
80%
Closely correlated
-2.73%
TPST - CALC
78%
Closely correlated
-1.24%
RZLT - CALC
78%
Closely correlated
-7.62%
GNTA - CALC
78%
Closely correlated
-1.27%
More